Scientists at the University of Würzburg have identified new molecular biomarkers for rare kidney tumors in small children. These may be targets for new therapies.
It is malignant and can occur in the first months of infants' lives or even before birth: congenital mesoblastic nephroma (CMN). Fortunately, the kidney tumor is very rare and can often be cured with surgery. However, there are no other specific treatment options - also because of the as yet unclarified causes of this tumor.
An enzyme becomes hyperactive
Three subtypes of this kidney tumor are known. An international team of researchers has now identified a genetic driver for one of these subtypes. Jenny Wegert and Professor Manfred Gessler from the Department of Developmental Biochemistry at the Biozentrum of Julius-Maximilians-University Würzburg (JMU) were responsible for this breakthrough, together with Sam Behjati and Grace Collord from the Wellcome Sanger Centre (Cambridge) and Christian Vokuhl from the University of Kiel. The results of their work are published in the current issue of the journal Nature Communications.
"Three subgroups can be defined in congenital mesoblastic nephroma in tissue sections: classical, cellular and mixed nephromas," explains Manfred Gessler. A characteristic change in the chromosomes has long been known to trigger cellular CMN. In this case, two genes fuse with each other, which leads to the overshooting activity of an enzyme. No typical genetic alterations were known for the classical variant of CMN, however.
Novel mutation detected
This has now changed: "By genome analysis of tumor and blood samples from patients, we were able to detect a novel mutation of the receptor for the epidermal growth factor, EGFR, in over 70 percent of classical CMN," Wegert describes the central result of the study. The scientists discovered a doubling of the enzymatically active kinase region in the genome of the affected cells. As a result, the EGF receptor becomes overactive and the tumor cells are permanently stimulated to grow. Further investigations have shown that in the majority of cases the mixed variant of the tumor also has such an EGFR mutation.
In both the classical and cellular variants of CMN, the genetic alterations trigger one of the most important signalling pathways for the activation of cell growth: the so-called MAP kinase cascade. Among other things, they switch on the BRAF kinase present in the cell. "Interestingly, the gene for this protein was also mutated in some of the tumors in which neither the mutation responsible for the classical nor the cellular variant could be detected," explained Gessler.
In these cases, the affected gene lost a region responsible for inhibiting BRAF kinase activity, with the result that the protein is permanently active and the MAP kinase cascade remains switched on.
Parallels to tumors in adults
The research team has thus succeeded in almost all cases in attributing this rare tumor of infancy to the activation of a central signalling pathway, which also plays an important role in many adult tumors, which Professor Andreas Rosenwald from the Institute of Pathology at the JMU was able to substantiate with corresponding staining of tumor section.
Especially for CMN patients who cannot be adequately treated surgically, these findings may now provide new treatment approaches by transferring proven principles of adult oncology to the therapy of congenital mesoblastic nephroma therapy.
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nature Communications, doi: 10.1038/s41467-018-04650-6, https://www.nature.com/articles/s41467-018-04650-6 .
University of Wuerzburg
Home to just under 29,000 students, Julius-Maximilians-Universität Würzburg (JMU) is one of the largest universities in Germany. True to its motto ‘Science for Society’, JMU is committed to advancing research in fields that are relevant for the future, focussing on eight pillars: Life Sciences / Health Sciences / Molecular Chemistry and Materials / Quantum Phenomena in New Materials / Digital Society / Cultural Heritage / Norms and Behavior / Global Changes.
The Wellcome Sanger Institute
The Wellcome Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. To celebrate its 25th year in 2018, the Institute is sequencing 25 new genomes of species in the UK.
Prof. Dr. Manfred Gessler, Chair of Developmental Biochemistry,
T: +49 931 31 84159 / 84160 (Secr.), email@example.com
Gunnar Bartsch | Julius-Maximilians-Universität Würzburg
Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY
NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Power and Electrical Engineering
20.07.2018 | Information Technology
20.07.2018 | Materials Sciences